CURE Media Group

The awards program will honor individuals who have made a significant difference in the lives of those affected by metastatic breast cancer.

Latasha Jordan and Aditya Bardia, M.D., MPH, share advice for patients and caregivers on the importance of a positive outlook and attitude when living with triple-negative breast cancer.

A triple-negative breast cancer (TNBC) survivor, Latasha Jordan, considers the positive impact her support network has had on her treatment; and Aditya Bardia, M.D., MPH, emphasizes the importance of social support systems for patients with TNBC.

Latasha Jordan discusses her experience in a clinical trial with sacituzumab govitecan and comments on the side effects she experienced as well as the overall impact on her quality of life.

An expert oncologist highlights the importance of discussing clinical trial options with patients and comments on the recent FDA approval of sacituzumab govitecan in triple-negative breast cancer based on the ASCENT 3 trial.

A patient with triple-negative breast cancer, Latasha Jordan, reflects on the mental and emotional challenges she faced when she learned of her disease progression and shares her positive experience with physician referral thereafter.

A leader in breast oncology and a triple-negative breast cancer survivor discuss the role of active surveillance for post-surgical disease progression and emphasize the importance of support from health care providers after recurrence.

Aditya Bardia, M.D., MPH, and triple-negative breast cancer survivor, Latasha Jordan, discuss the importance of shared decision-making when considering mastectomy or lumpectomy and radiation for triple-negative breast cancer.

Latasha Jordan discusses her experience with neoadjuvant chemotherapy, and an expert in the management of breast cancer, Aditya Bardia, M.D., MPH, reviews common side events associated with systemic treatment.

View the full CURE Educated Patient Lung Cancer Summit on demand.

View the full CURE Educated Patient Lung Cancer Summit on demand.

View the full CURE Educated Patient Lung Cancer Summit on demand.

Twelve hikers will embark on this incredible challenge to raise awareness and funds for multiple myeloma through the Multiple Myeloma Research Foundation.

View the full CURE® Educated Patient® Webinar: Gastrointestinal Stromal Tumor (GIST).

Industry-leading multimedia platform joins forces with well-renowned non-profit organization to help save lives, celebrate lives, and lead the fight for a world without cancer.

The basics of uveal melanoma

Discussing emerging therapies in melanoma

Understanding Immune-Modulating Antibodies

Updates in adjuvant and neoadjuvant therapy in melanoma

Anna C. Pavlick, D.O., describes the various challenges health care providers may face when treating patients with locally advanced basal cell carcinoma (laBCC).

Insights into cemiplimab treatment monitoring and management in locally advanced basal cell carcinoma (laBCC).

An expert discusses treatment options available for patients with locally advanced basal cell carcinoma (laBCC) who don’t respond or are intolerant to the first-line therapy option.

View the full CURE® Educated Patient® Webinar: Biomarkers, Why Genomic Testing Matters on demand.

Anna C. Pavlick, DO, provides an overview of hedgehog inhibitors, a first-line treatment option for patients diagnosed with locally advanced basal cell carcinoma (laBCC).

A discussion about multidisciplinary management of locally advanced basal cell carcinoma (laBCC) and how dermatologists and medical oncologists collaborate within the care of a patient.

An expert discusses features of a skin lesion that would prompt a skin biopsy in the diagnosis of locally advanced basal cell carcinoma (laBCC).

Anna C. Pavlick, D.O., provides an overview of locally advanced basal cell carcinoma (laBCC) that includes the different risk factors and clinical presentations.

View the full CURE Educated Patient Skin Cancer Summit on demand.

Dr. Yanghee Woo highlights barriers that patients with gastric cancer face when looking to enroll in a clinical trial, and comments on the need for more participation in research trials that investigate ways to improve how the condition is screened for and treated.

Dr. Sam Klempner describes limitations in caring for patients with gastric cancer and emphasizes the importance of participation in clinical trials to help advance treatment.